Related coverage linked through entity extraction aliases.
May 25, 2026
New market reports project strong growth in pharmaceutical manufacturing: fill-finish is set to reach $21.04 billion by 2030, ampoule filling/sealing machines to grow at a 5.8% CAGR through 2035, and medical membranes to hit $6.6 billion by 2030.
Mar 05, 2026
The large molecule drug substance CDMO market is expected to grow at approximately 9% CAGR through 2031, driven by rising demand for biologics and biosimilars, streamlined regulatory approval pathways, and increasing FDA and EMA approvals for biologic therapies.
Mar 04, 2026
Scholar Rock plans to resubmit its biologics license application for apitegromab in spinal muscular atrophy following FDA reinspection of the Catalent Indiana fill-finish facility, with a U.S. launch anticipated in 2026.
